High rates of 30-day mortality in patients with cirrhosis and COVID-19

BACKGROUND & AIMS: Coronavirus disease 2019 (COVID-19) poses a major health threat to healthy individuals and those with comorbidities, but its impact on patients with cirrhosis is currently unknown. Herein, we aimed to evaluate the impact of COVID-19 on the clinical outcome of patients with cir...

Descripción completa

Detalles Bibliográficos
Autores principales: Iavarone, Massimo, D'Ambrosio, Roberta, Soria, Alessandro, Triolo, Michela, Pugliese, Nicola, Del Poggio, Paolo, Perricone, Giovanni, Massironi, Sara, Spinetti, Angiola, Buscarini, Elisabetta, Viganò, Mauro, Carriero, Canio, Fagiuoli, Stefano, Aghemo, Alessio, Belli, Luca S., Lucà, Martina, Pedaci, Marianna, Rimondi, Alessandro, Rumi, Maria Grazia, Invernizzi, Pietro, Bonfanti, Paolo, Lampertico, Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Association for the Study of the Liver. Published by Elsevier B.V. 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280108/
https://www.ncbi.nlm.nih.gov/pubmed/32526252
http://dx.doi.org/10.1016/j.jhep.2020.06.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280108/
https://www.ncbi.nlm.nih.gov/pubmed/32526252
http://dx.doi.org/10.1016/j.jhep.2020.06.001

Ejemplares similares